Agilon Health, Inc. (the "Company") has filed an amendment to its Amended and Restated Certificate of Incorporation to implement a reverse stock split of its common stock at a ratio of 1-for-25. This decision follows the approval by the Company's stockholders during the Special Meeting held on March 17, 2026. The reverse stock split will take effect at 4:36 p.m. Eastern Time on March 30, 2026. As a result of the split, every twenty-five shares of common stock will be combined into one share. The Company will not issue fractional shares; instead, stockholders entitled to receive fractional shares will receive cash in lieu of such shares. The reverse stock split is expected to enhance the marketability of the Company's common stock and is part of a broader strategy to improve shareholder value. Trading on the New York Stock Exchange will commence on a split-adjusted basis on March 31, 2026, under the existing trading symbol "AGL." The new CUSIP number for the Company's common stock following the reverse stock split is 00857U 206. This strategic move is anticipated to positively influence the stock price by improving liquidity and attracting a broader range of investors.

Press Release distribution

National Press Distribution across U.S. Media. Direct Access to Key Decision Making Editors.